Bio-Rad Laboratories, Inc. BIO.B Clinical Diagnostics — Income from operations
Discontinued — last reported Q1 '23
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed May 5, 2023, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s clinical diagnostics — income from operations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s clinical diagnostics — income from operations?
- Bio-Rad Laboratories, Inc. (BIO.B) reported clinical diagnostics — income from operations of $26.3M in Q1 2023.
- How has Bio-Rad Laboratories, Inc.'s clinical diagnostics — income from operations changed year-over-year?
- Bio-Rad Laboratories, Inc.'s clinical diagnostics — income from operations decreased by 53.9% year-over-year, from $57.1M to $26.3M.
- What does clinical diagnostics — income from operations mean?
- The operating profit of the Clinical Diagnostics segment, calculated as net sales minus cost of goods sold and operating expenses (such as R&D, SG&A, and restructuring charges). It measures the core profitability of the segment's business activities before interest and taxes.